Product Segment Analysis: Balloon-expandable Stents (Largest Segment) vs Self-expandable Stents (Fastest-Growing Segment)

Balloon-expandable stents held the largest position in the pulmonary stents market in 2026, with a 56.07% share. Their established role is associated with the ability to provide controlled expansion and precise placement within narrowed pulmonary vessels, making them useful where accurate stent positioning is important. These devices can support restoration of vessel patency in complex pulmonary conditions and offer clinicians greater control during deployment. Continued demand for minimally invasive approaches to pulmonary vascular interventions supports the segment's strong market presence.

Self-expandable stents are the fastest-growing product segment, benefiting from their ability to conform to vessel anatomy and maintain expansion after deployment. Their flexibility can be advantageous in anatomically challenging pulmonary interventions where changes in vessel diameter or curvature require greater adaptability. Advances in stent design and increasing attention to minimally invasive treatment options are broadening the applicability of self-expanding technologies, supporting their expanding role in pulmonary vascular procedures.

Type Segment Analysis: Tracheobronchial Stents (Largest Segment) vs Laryngeal Stents (Fastest-Growing Segment)

The tracheobronchial stents segment dominated the pulmonary stents market in 2026, accounting for a 69.24% share. Its leading position reflects the established clinical need to maintain airway patency in patients experiencing obstruction or narrowing within the trachea and bronchi. These stents can provide structural support to compromised airways and help improve airflow, making them important in the management of complex respiratory conditions. Increasing reliance on minimally invasive airway interventions and the need for effective management of obstructive conditions continue to sustain demand for tracheobronchial stenting.

Laryngeal stents represent the fastest-growing type segment, supported by increasing attention to minimally invasive approaches for managing airway narrowing and structural abnormalities around the laryngeal region. Their application can help maintain airway passage while addressing conditions that may otherwise require more invasive intervention. Improvements in stent materials, deployment techniques, and patient-specific airway management are creating opportunities for broader use of laryngeal stents within specialized respiratory and otolaryngology procedures.